Sirona Biochem Corp. Stock
Your prediction
Pros and Cons of Sirona Biochem Corp. in the next few years
Pros
?
M***** P*******
?
S********** s********
?
W********* I********* f** t** n*** y****
Cons
?
G***** c******* t* c**********
?
C******** o* t** e**********
?
B****
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Sirona Biochem Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Sirona Biochem Corp. | - | - | - | - | - | - | - |
| Satellos Bioscience Inc. | -3.920% | -2.970% | -5.314% | -27.407% | -30.000% | 169.231% | - |
| Vaxart Inc. | 7.630% | 3.524% | -3.093% | -50.526% | -58.160% | -67.331% | -95.220% |
| Larimar Therapeutics Inc. | 0.600% | 15.172% | 7.051% | -9.730% | -10.215% | -26.754% | -80.871% |
Comments
News
Dentsply Sirona (XRAY) Q2 Sales Drop 5%
Dentsply Sirona (NASDAQ:XRAY), a major player in dental products and technologies, released its second quarter results on August 7, 2025. The company reported GAAP revenue of $936 million and
